Amazon cover image
Image from Amazon.com

From science 2.0 to pharma 3.0 : semantic search and social media in the pharmaceutical industry and STM publishing / Hervé Basset, David Stuart and Denise Silber ; with contributions from François Boutin.

By: Contributor(s): Material type: TextTextSeries: Chandos social media series ; 7.Publication details: Witney, Oxford : Chandos Publishing/Woodhead Publishing Limited, ©2012.Description: 1 online resource (xvi, 276 pages) : illustrationsContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781780633756
  • 1780633750
  • 1306176735
  • 9781306176736
Other title:
  • Semantic search and social media in the pharmaceutical industry and STM publishing
Subject(s): Additional physical formats: Print version:: From Science 2.0 To Pharma 3.0 : Semantic Search And Social Media In The Pharmaceutical Industry And Stm Publishing.DDC classification:
  • 501/.4 23
LOC classification:
  • HM742 .B37 2012
NLM classification:
  • 2013 E-405
  • Q 224.5
Online resources:
Contents:
Part 1. From science 2.0 (2000-2010) ... ; The web 2.0 revolution and the promise of science 2.0 / David Stuart -- The state of science 2.0 / David Stuart -- Part 2. ... And pharma 2.0 ... ; Health 2.0 and beyond / Denise Silber -- The digital pharma industry / Hervé Bassett, with contributions from Paul Tunnah and Andrew Spong -- Part 3. ... to pharma 3.0 (2010- ) ; The semantic search in life sciences / Hervé Bassett and François Boutin -- Enterprise 2.0 and web 3.0 / Hervé Bassett -- The next 3.0 / Hervé Bassett -- Conclusion.
Summary: Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilize digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of '3.0' in Pharma and STM publishing.
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
eBook eBook e-Library EBSCO Computers Available
Total holds: 0

Includes lists of figures and abbreviations, notes and bibliographical references at chapter ends, bibliographical references (pages 237-269), and index.

Part 1. From science 2.0 (2000-2010) ... ; The web 2.0 revolution and the promise of science 2.0 / David Stuart -- The state of science 2.0 / David Stuart -- Part 2. ... And pharma 2.0 ... ; Health 2.0 and beyond / Denise Silber -- The digital pharma industry / Hervé Bassett, with contributions from Paul Tunnah and Andrew Spong -- Part 3. ... to pharma 3.0 (2010- ) ; The semantic search in life sciences / Hervé Bassett and François Boutin -- Enterprise 2.0 and web 3.0 / Hervé Bassett -- The next 3.0 / Hervé Bassett -- Conclusion.

Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilize digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of '3.0' in Pharma and STM publishing.

Print version record.

Added to collection customer.56279.3

Powered by Koha